Lupus Research Alliance News
Hydroxychloroquine: Common Lupus Drug in Testing for COVID-19

March 19, 2020 In December 2019, a new virus called SARS-COV-2 was identified in Wuhan, China. This virus was found to cause a severe respiratory illness in patients which was later named after the type of virus that caused it and the year it was identified (coronavirus disease 2019 or COVID-19)1 Currently there is no […] READ MORE

Actualización sobre COVID-19: un mensaje del presidente y director ejecutivo de la LRA

18 de marzo de 2020 Estimados amigos: Su bienestar es la máxima prioridad para todos nosotros en la Alianza para la investigación de Lupus (Lupus Research Alliance, LRA). Estamos consultando a los mejores clínicos y científicos especializados en lupus para supervisar la situación planteada por la propagación del coronavirus SARS (SARS-CoV-2), comúnmente denominado COVID-19, en […] READ MORE

COVID-19 Update: A Message from LRA President & CEO

March 18, 2020 Dear Friends, Your well-being is the utmost priority for all of us at the Lupus Research Alliance (LRA). We are consulting with top lupus clinicians and scientists in monitoring the situation posed by the spread of the SARS coronavirus (SARS-CoV-2) often referred to as COVID-19, across the world and committed to doing […] READ MORE

Preguntas frecuentes sobre la COVID-19: Lo que hay que saber

13 de marzo de 2020 La prioridad de Lupus Research Alliance es la salud de las personas que viven con lupus. Nos estamos asesorando con las autoridades sanitarias y estamos monitoreando la situación causada por la propagación de la enfermedad por coronavirus denominada COVID-19. La siguiente es una lista de preguntas frecuentes para ayudar a […] READ MORE

Aurinia Moves Voclosporin Closer to FDA Approval for Lupus Nephritis

March 16, 2020 The Lupus Research Alliance is pleased to share an announcement from Aurinia Pharmaceuticals that moves its potential treatment for lupus nephritis, voclosporin, one step closer to approval by the U.S. Food and Drug Administration (FDA).  The Company announced in a press release March 16 that it has started a Rolling Submission of […] READ MORE

COVID-19 Frequently Asked Questions: What You Should Know

Updated April 3, 2020 The first priority of the Lupus Research Alliance is the health of our lupus community.  We have been consulting with health care authorities and monitoring the situation created by the spread of COVID-19. Please note that every lupus patient is different. If you have specific questions about your condition and/or any […] READ MORE

It’s Not Too Late to Advocate for Lupus Research!

March, 2020 Congress will be working on the Fiscal Year 2021 budget for weeks to come, so you can still make your voice heard for lupus research.  If you haven’t already, please go online TODAY and use the automated tools of our Legislative Action Center to tell legislators what lupus research means to their constituents […] READ MORE

Common Lupus Medication May Protect Against Type 2 Diabetes

March 9, 2020 A newly published study showed that antimalarial medications, a common form of treatment for lupus, may help prevent type 2 diabetes mellitus (T2DM), which can be a complication of the disease and a side effect of medications like glucocorticosteroids. Researchers reviewed health databases in British Columbia Canada to study the incidence of […] READ MORE

Living in a Disadvantaged Neighborhood Lowers Follow-up Care

March 4, 2020 A new study showed that living in a disadvantaged neighborhood predicts poor retention (follow-up) care for people with lupus.  Retention was defined specifically has having two out-patient doctor visits or lab tests such as measuring complement levels. Researchers looked at the records of 397 patients with lupus in terms of age, sex, […] READ MORE

Coronavirus Disease Info for People with Lupus

Updated March 11, 2020 On behalf of our lupus community, the Lupus Research Alliance is following closely reports from the U.S. Centers for Disease Control and Prevention (CDC), the country’s health protection agency, about the Coronavirus Disease 2019 called COVID-19. People with lupus are predisposed (at greater risk) to infections because of both their disease […] READ MORE

la Alianza para la investigación de Lupus (Lupus Research Alliance) está siguiendo de cerca los informes de los Centros para el Control y la Prevención de Enfermedades de los Estados Unidos(CDC) sobre la enfermedad de COVID-19

Poner al día 11 Marzo de 2020 En nombre de nuestra comunidad de lupus, la Alianza para la investigación de Lupus (Lupus Research Alliance) está siguiendo de cerca los informes de los Centros para el Control y la Prevención de Enfermedades de los Estados Unidos (CDC), la agencia de protección de la salud del país, […] READ MORE

Learn and connect with our community!